Publication | Closed Access
Ambroxol inhibits endotoxin-induced lipid peroxidation in mice.
23
Citations
0
References
1993
Year
InflammationOxysterolImmunotoxicologyMedicineLipid PeroxidationPhysiologyHeart LipidsPulmonary PharmacologyToxicologyEndotoxin-induced Lipid PeroxidationReactive Oxygen SpecieCardiovascular ToxicityPharmacologyHeart LevelsOxidative Stress
Administration of ambroxol (70 mg/kg ip) once a day for 3 days protected lung and heart lipids from lipopolysaccharide (LPS, 17 mg/kg)-induced oxidative stress in mice. Ambroxol as a lipid peroxidation inhibitor was almost as active as an equivalent dose of N-acetylcysteine (27.6 mg/kg), a well known antioxidant. The lung and heart levels of conjugated dienes in animals pretreated with ambroxol were 3.3- and 1.7-times lower (p < 0.05 and p < 0.01) than those observed in the control group which received only buffer and subsequently LPS. These results indicate that ambroxol can sufficiently inhibit the harmful process of lipid peroxidation in vivo.